NCT07093775View on ClinicalTrials.gov

Additional Prognostic Value of Tumor Grade Beyond the 21-gene Recurrence Score

Not yet recruitingOBSERVATIONAL

Enrollment

4,000

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions

Breast CancerTumor Grade

Interventions

OTHER

Tumor grade (I or II vs. III)

We compared the prognosis according to the tumor grade stratified by 21-gene recurrence score

All Listed Sponsors

lead

Gangnam Severance Hospital

OTHER